BioCentury | Jan 4, 2019
Company News

Novartis shares data on discontinued antibiotic research

...Novartis shared data from its bacterial UDP-N-acetylglucosamine acyltransferase (LpxA), bacterial UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase (LpxD) and bacterial tetraacyldisaccharide 4'-kinase family protein (LpxK)...
...Basel, Switzerland The Pew Charitable Trusts, Philadelphia, Pa. Business: Infectious disease Steve Usdin Novartis AG The Pew Charitable Trusts Bacterial tetraacyldisaccharide 4'-kinase family protein (LpxK) Bacterial...
BioCentury | Jun 1, 2018
Emerging Company Profile

Scratching the surface

Oppilotech Ltd. is using computational modeling to develop first-in-class compounds that can permeate the lipopolysaccharide layer of the outer cell membrane of Gram-negative bacteria to potentiate existing antibiotics. Marketed polymyxins are used to disrupt the...
Items per page:
1 - 2 of 2